AstraZeneca, LSE and Heathrow among 320 co's to make nature-based disclosures in financial resultsProactive Investors • 01/16/24
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract CancerPRNewsWire • 01/08/24
Omniose Announces Scientific Collaboration With AstraZeneca to Research Vaccines for Serious Bacterial DiseasesBusiness Wire • 01/05/24
Turbine Announces Collaboration to Uncover Biological Mechanisms of Drug Resistance in Hematological CancersBusiness Wire • 01/05/24
GSK gets shot in arm from upgrade, AstraZeneca mixed reviews after China dealProactive Investors • 01/03/24
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZenecaPRNewsWire • 01/02/24
AstraZeneca to Acquire China's Gracell in $1.2 Billion Deal to Further Cell Therapy GoalsBarrons • 12/26/23
Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatmentMarket Watch • 12/22/23